Walter E Haefeli

InstitutionUniversity of Heidelberg
AddressHeidelberg
Germany
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 5 Covid-19 publications, with a maximum of 1 publications in June 2020 and Spetember 2020 and December 2020 and January 2021 and February 2021
    All Publications
    Bar chart showing 293 publications over 20 distinct years, with a maximum of 31 publications in 2014
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Weiss J, Bajraktari-Sylejmani G, Haefeli WE. Low risk of the TMPRSS2 inhibitor camostat mesylate and its metabolite GBPA to act as perpetrators of drug-drug interactions. Chem Biol Interact. 2021 Apr 01; 338:109428. PMID: 33647240.
      Citations:    Fields:    Translation:HumansCells
    2. Röhr S, Zülke A, Luppa M, Brettschneider C, Weißenborn M, Kühne F, Zöllinger I, Samos FZ, Bauer A, Döhring J, Krebs-Hein K, Oey A, Czock D, Frese T, Gensichen J, Haefeli WE, Hoffmann W, Kaduszkiewicz H, König HH, Thyrian JR, Wiese B, Riedel-Heller SG. Recruitment and Baseline Characteristics of Participants in the AgeWell.de Study-A Pragmatic Cluster-Randomized Controlled Lifestyle Trial against Cognitive Decline. Int J Environ Res Public Health. 2021 01 07; 18(2). PMID: 33430189.
      Citations: 2     Fields:    Translation:Humans
    3. Wagner L, Haefeli WE, Merle U, Lorenz HM, Hohmann N, Weiss J, Theile D. A nuclear factor kappa B reporter cell line used to evaluate ex vivo the net inflammatory effect of plasma samples from patients with rheumatoid arthritis, psoriasis, or COVID-19. Cytokine. 2021 02; 138:155399. PMID: 33338916.
      Citations:    Fields:    Translation:HumansCells
    4. Weiss J, Bajraktari-Sylejmani G, Haefeli WE. Interaction of Hydroxychloroquine with Pharmacokinetically Important Drug Transporters. Pharmaceutics. 2020 Sep 25; 12(10). PMID: 32992777.
      Citations: 1     
    5. Stoll F, Blank A, Mikus G, Czock D, Foerster KI, Hermann S, Häußler K, Muhareb A, Hummler S, Weiss J, Burhenne J, Haefeli WE. Impact of pantoprazole on absorption and disposition of hydroxychloroquine, a drug used in Corona Virus Disease-19 (Covid-19): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 29; 21(1):584. PMID: 32600363.
      Citations:    Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials